Sohrab Moradi

Moradi at the [[Weightlifting at the 2016 Summer Olympics – Men's 94 kg|2016 Summer Olympics]] Sohrab Moradi (, born 22 September 1988) is a current world record holding retired Iranian weightlifter who won the gold medal in the 94 kg weight division at the 2016 Olympics. He currently holds the world record with a total of 417kg in the 94kg weight class. He formerly held world records in the snatch and clean and jerk categories. He was the Asian champion in the 85 kg weight class in 2009 and 2012.

In 2013, he was banned from the sport for two years for doping, after testing positive for methadone. Any opioid, in general, causes suppression of testosterone and therefore, it is likely that individuals entering methadone treatment already have reduced testosterone levels. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Sohrab Moradi', query time: 0.03s Refine Results
  1. 1
    A modified method for transformation of Fusarium graminearum

    A modified method for transformation of Fusarium graminearum by Sohrab Moradi, Forough Sanjarian, Naser Safaie, Amir Mousavi, Gholam Reza Bakhshi Khaniki

    Published 2013-09-01
    Get full text
    Article
  2. 2
    Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial

    Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial by Mohammadreza Ahi, Ramin Hamidi Farahani, Pouria Basiri, Ahmad Karimi Rahjerdi, Ali Sheidaei, Kimiya Gohari, Zahra Rahimi, Fatemeh Gholami, Milad Moradi, Farzad Ghafoori Naeeni, Kosar Naderi Saffar, Soheil Ghasemi, Babak Barati, Sohrab Moradi, Arina Monazah, Fatemeh Pouranvari, Mohsen Forooghizadeh

    Published 2022-10-01
    Get full text
    Article
  3. 3
    Development of Inactivated FAKHRAVAC<sup>®</sup> Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models

    Development of Inactivated FAKHRAVAC<sup>®</sup> Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models by Soheil Ghasemi, Kosar Naderi Saffar, Firooz Ebrahimi, Pezhman Khatami, Arina Monazah, Ghorban-Ali Alizadeh, Hossein-Ali Ettehadi, Iman Rad, Shahrzad Nojehdehi, Mousa Kehtari, Fatemeh Kouhkan, Hesam Barjasteh, Sohrab Moradi, Mohammad-Hosein Ghorbani, Ali Khodaeipour, Moslem Papizadeh, Roghayeh Najafi, Ehsan Naghneh, Davood Sadeghi, Ahmad Karimi Rahjerdi

    Published 2021-11-01
    Get full text
    Article
  4. 4
    Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18–70 years

    Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18–70 years by Fatemeh Gholami, Ramin Hamidi Farahani, Ahmad Karimi Rahjerdi, Mohammadreza Ahi, Ali Sheidaei, Kimiya Gohari, Zahra Rahimi, Akram Ansarifar, Pouria Basiri, Milad Moradi, Arash Jahangiri, Kosar Naderi, Soheil Ghasemi, Pezhman Khatami, Mohsen Honari, Samane Khodaverdloo, Mohammad Shooshtari, Hajar Mehr Azin, Sohrab Moradi, Batool Shafaghi, Hossein Allahyari, Arina Monazah, Ali Khodaei Poor, Zahra Taghva, Hooman Bakhshande, Mohammad Karimi Nia, Masoud Solaymani Dodaran, Mohsen Forooghizade

    Published 2023-02-01
    Get full text
    Article
  5. 5
    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18–55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial

    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18–55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial... by Akram Ansarifar, Ramin Hamidi Farahani, Ahmad Karimi Rahjerdi, Mohammadreza Ahi, Ali Sheidaei, Kimiya Gohari, Zahra Rahimi, Fatemeh Gholami, Pouria Basiri, Milad Moradi, Arash Jahangiri, Kosar Naderi, Soheil Ghasemi, Pezhman Khatami, Mohsen Honari, Samane Khodaverdloo, Mohammad Shooshtari, Hajar Mehr Azin, Sohrab Moradi, Batool Shafaghi, Hossein Allahyari, Arina Monazah, Ali Khodaei Poor, Hooman Bakhshande, Zahra Taghva, Mohammad Karimi Nia, Masoud Solaymani Dodaran, Mohsen Foroughizadeh

    Published 2023-12-01
    Get full text
    Article

Search Tools: